Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001198521 | SCV001369487 | uncertain significance | Rubinstein-Taybi syndrome due to CREBBP mutations | 2019-08-20 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3. |
Labcorp Genetics |
RCV003759032 | SCV004557277 | likely benign | Rubinstein-Taybi syndrome | 2024-03-24 | criteria provided, single submitter | clinical testing |